Profile
Elysian Capital LLP is a private equity firm based in London. Founded with a focus on supporting entrepreneurial management, the firm is led by a team experienced in entrepreneurial, operational, and investment skills. The culture at Elysian is described as entrepreneurial and aligned, emphasizing its commitment to backing and supporting aspirational management teams. The firm prioritizes alignment with its management teams, dedicating personal capital to investments more than usual in the industry.
Elysian Capital invests across various sectors including healthcare services, industrials, business services, and energy. Typical investment sizes range from mid-market buyouts and expansions, with the firm managing funds such as Elysian Capital I with £115 million, Elysian Capital II with £222 million, and Elysian Capital III with £288 million. They mainly focus on the UK and European mid-market, partnering with management teams to maximize value creation.
Notable investments of Elysian Capital include IMS Euro - healthcare services, Activate Group - business services, D3O - industrials, Gravity Global - business services, and Cross Rental Services - business goods. They collaborate closely with management to enhance operational expertise and create value.
Industry
Elysian Capital LLP Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Elysian Capital I
|
Private Equity (PE)
Venture Capital (VC)
|
HealthTech
Energy
MedTech
Utilities
Travel
Transportation
Sports/SportsTech
Real Estate
Oil and Gas
Industrial
Healthcare Services
Foodtech
Food and Beverage
Consumer Products
Business Services (B2B)
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$115 M
|
September 2026
|
|
Elysian Capital II
|
Private Equity (PE)
Venture Capital (VC)
|
HealthTech
Energy
MedTech
Utilities
Travel
Transportation
Sports/SportsTech
Real Estate
Oil and Gas
Industrial
Healthcare Services
Foodtech
Food and Beverage
Consumer Products
Business Services (B2B)
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$222 M
|
September 2026
|
|
Elysian Capital III
|
Private Equity (PE)
Venture Capital (VC)
|
HealthTech
Energy
MedTech
Utilities
Travel
Transportation
Sports/SportsTech
Real Estate
Oil and Gas
Industrial
Healthcare Services
Foodtech
Food and Beverage
Consumer Products
Business Services (B2B)
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$288 M
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.